Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

EASL 2020 Virtual Conference: Rapid Audio Recap

August 27-29, 2020; Virtual
Hear insights from hepatology expert, Stefan Zeuzem, MD, on some of the most important new viral hepatitis data reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver. The studies highlighted in this podcast focus on HCV elimination and the treatment of HCV, HBV, and HDV infection.
Stefan Zeuzem, MD
Released: September 14, 2020

In this episode, Dr. Stefan Zeuzem discusses results from key viral hepatitis studies reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver, including important findings from the following reports:

  • Update on global progress toward HCV elimination goals
  • SToP-C: HCV treatment-as-prevention in Australian prisons
  • SHARED cohort: correlates of treatment failure with GLE/PIB or SOF/VEL/VOX
  • Trio Health: retreating HCV with GLE/PIB or SOF/VEL/VOX after DAA failure
  • Stop-NUC: discontinuation of long-term nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic HBV infection
  • High-dose bulevirtide for chronic HBV/HDV coinfection
  • Summary of select agents under early-phase investigation for HBV treatment

Content based on a CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/hepatitis/conference-coverage/easl-2020/highlights

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences

Related Content

CCO module from Tatyana Kushner, MD, MSCE, reviewing new HCV screening and management guidelines for young women of reproductive potential in the US

Tatyana Kushner, MD, MSCE Physicians: maximum of 1.0 AMA PRA Category 1 Credit ABIM MOC: maximum of 1.0 Medical Knowledge MOC point(s) Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Released: December 1, 2020 Expired: November 30, 2021

CCO expert slideset of key viral hepatitis data from AASLD 2020, including data on HBV management, identifying risk for HCC, trends in HCV treatment outcomes, and more

Norah Terrault Headshot Norah Terrault, MD, MPH Released: November 25, 2020

Norah Terrault, MD, MPH, discusses new viral hepatitis data reported at the virtual AASLD 2020 liver meeting, in the CCO Infectious Disease podcast

Norah Terrault Headshot Norah Terrault, MD, MPH Released: November 25, 2020

Download free expert-authored slides on improving hepatitis C care by increasing access to care and streamlining testing and diagnosis.

Stacey Trooskin, MD, PhD Released: November 2, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue